<DOC>
	<DOCNO>NCT01853722</DOCNO>
	<brief_summary>This proof-of-concept study evaluate clinical efficacy safety DCN01 prepping periocular region .</brief_summary>
	<brief_title>A Phase 2 , Open-Label , Randomized , Parallel Group , Placebo-Controlled , Single-Center Study Assess Anti-microbial Efficacy Safety DCN01 Compared UnisolÂ® Following Topical Periocular Administration Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Have give write , inform consent Be willing able follow instruction A negative urine pregnancy test female childbearing potential Known sensitivity study medication component Any sign active infection Use disallow product period indicate prior enrollment study Be currently pregnant , nursing , plan pregnancy ; woman positive pregnancy test Have condition situation , Investigator 's opinion , may put subject increase risk , confound study data , interfere significantly subject 's study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>DCN01</keyword>
	<keyword>Ocular Surgical Preparation</keyword>
	<keyword>Prophylaxis infection</keyword>
	<keyword>Pre-operative prep</keyword>
</DOC>